AlloVir Inc.

NASDAQ: ALVR · Real-Time Price · USD
9.81
0.39 (4.14%)
At close: Mar 18, 2025, 3:59 PM

AlloVir Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-58.77M -190.42M -168.71M -171.96M
Depreciation & Amortization
n/a 398K 723K 189K
Stock-Based Compensation
26.35M 40.78M 41.31M 43.98M
Other Working Capital
3.35M 4.59M -3.52M -936K
Other Non-Cash Items
-9.98M 22.77M 766K 928K
Deferred Income Tax
n/a n/a n/a 1.2M
Change in Working Capital
-25.3M 2.02M -16.15M 19.35M
Operating Cash Flow
-67.7M -124.45M -142.05M -106.32M
Capital Expenditures
n/a n/a 104K -26K
Cash Acquisitions
n/a n/a n/a -186.01K
Purchase of Investments
n/a -125.83M -228.81M -76.59M
Sales Maturities Of Investments
95M 163.81M 148.33M 262.6M
Other Investing Acitivies
n/a n/a -104K 186.01K
Investing Cash Flow
95M 37.98M -80.48M 185.98M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
21K 326K 536K 232K
Financial Cash Flow
21K 70.5M 126.96M 232K
Net Cash Flow
27.32M -15.97M -95.57M 79.85M
Free Cash Flow
-67.7M -124.45M -141.95M -106.34M